MYOMO, INC. (MYO)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Revenue | 9,652,234 | 9,831,814 | 9,207,586 | |
| Cost of revenue | 3,600,061 | 3,222,184 | 2,262,031 | |
| Gross profit | 6,052,173 | 6,609,630 | 6,945,555 | |
| Selling, clinical and marketing | 5,233,885 | 4,395,804 | 3,401,182 | |
| Research and development | 2,001,331 | 1,790,024 | 1,248,870 | |
| General and administrative | 3,407,277 | 3,944,056 | 3,253,056 | |
| Total operating expenses | 10,642,493 | 10,129,884 | 7,903,108 | |
| Loss from operations | -4,590,320 | -3,520,254 | -957,553 | |
| Interest (income), net | 106,549 | 191,991 | 76,020 | |
| Total other (income), net | 106,549 | 191,991 | 76,020 | |
| Loss before income taxes | -4,483,771 | -3,328,263 | -881,533 | |
| Income tax expense | 148,201 | 136,795 | 84,876 | |
| Net loss | -4,631,972 | -3,465,058 | -966,409 | |
| Basic | -0.11 | -0.08 | -0.03 | |
| Basic | 41,582,737 | 41,454,472 | 37,950,515 | |
| Diluted | -0.11 | -0.08 | -0.03 | |
| Diluted | 41,582,737 | 41,454,472 | 37,950,515 | |